Xenon Pharmaceuticals (XENE)
(Delayed Data from NSDQ)
$37.76 USD
+1.06 (2.89%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $37.76 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Xenon Pharmaceuticals Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
XENE 37.76 +1.06(2.89%)
Will XENE be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for XENE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for XENE
Why Is Xenon Pharmaceuticals (XENE) Up 4.2% Since Last Earnings Report?
Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus
XENE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Xenon Pharmaceuticals (XENE) Up 8.7% Since Last Earnings Report: Can It Continue?
Xenon Q1 Loss Narrower Than Expected, Pipeline Development in Focus
Wall Street Analysts See a 48.15% Upside in Xenon Pharmaceuticals (XENE): Can the Stock Really Move This High?
Other News for XENE
Crossed Above 200 Day Moving Average appears for XENE after 2.92% move
COMMODORE CAPITAL LP Acquires Significant Stake in Terns Pharmaceuticals Inc
Jefferies Reaffirms Their Buy Rating on Xenon (XENE)
XENE forms Non-ADX 1,2,3,4 Bullish on September 16
XENE forms 200 Day Moving Average Support on September 15